Quality Control: A Prospective Analysis of EVD Effectiveness

Age Range:18 - 75
Start Date:April 2016
End Date:July 2018
Contact:Beverly A Roy, M-HR

Use our guide to learn which trials are right for you!

Quality Control: A Prospective Analysis of External Ventricular Drain (EVD) Effectiveness

The purpose and/or hypothesis: To decrease the amount of external ventricular drain (EVD)
related catheter infections by comparing the efficacy of Oklahoma University Medicine
standard EVD catheters, both impregnated and non-impregnated, in three principle areas:
incidence of infection, cost analysis, and average durations of placement, all while
maintaining the standards of technique.

Experimental design: Track external ventricular drain (EVD) associated infections and through
quality prospective analysis and compare the usage of standard catheters used by the
department here at Oklahoma University, 1) the 35cm Codman Bactiseal rifampin and clindamycin
impregnated catheter, 2) the Ventriclear EVD Antibiotic Catheter, and 3) the 36 cm Integra
Hermatic large style ventricular catheter, in terms of incidence of infections, cost,
duration of placement, and differences in placement technique.

Proposed procedure: Monitor for infections associated with and related to EVD placement in
patients and assess if infections rates are affected by usage of antibiotic impregnated EVD

Importance of knowledge reasonably expected to result from the research: While use of sterile
techniques and periprocedural antibiotics have traditionally been used to combat infection,
infection rates remain above goal leading to the question of whether the antibiotic
impregnated catheter should be added to the standard of care. With the knowledge gained, the
investigators hope to decrease the amount of external ventricular drain related catheter
infections and reduce use of prolonged antibiotics.

Inclusion Criteria:

- Patients who require placement of external ventricular drain.

Exclusion Criteria:

- Prisoners and/or those who may be pregnant.
We found this trial at
Oklahoma City, Oklahoma 73104
Principal Investigator: Bradley Bohnstedt, MD
Phone: 405-271-4912
Oklahoma City, OK
Click here to add this to my saved trials